Global data show real-world effectiveness of romosozumab for patients at high fracture risk
UCB, a global biopharmaceutical company, today announced findings from a collection of real-world evidence studies to reaffirm the effectiveness and clinical impact of romosozumab, the only dual-acting osteoporosis treatment that…
Arm fat may reveal women and men at risk of spinal fracture
Measuring the total mass of fat in the arms could potentially predict which women and men over 50 are at risk of spinal fracture, according to research presented at the…